Biomimetic Multilayered Lipid Nanovesicles for Potent Protein Vaccination
Authors:
Open Access
- 14 June 2024
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 13 (18) , e2304109
Abstract
Lipid vesicles are widely used for drug and gene delivery, but their structural instability reduces in vivo efficacy and requires specialized handling. To address these limitations, strategies like lipid cross‐linking and polymer–lipid conjugation are suggested to enhance stability and biological efficacy. However, the in vivo metabolism of these altered lipids remains unclear, necessitating further studies. A new stabilization technique without chemical modification is urgently needed. Here, a bio‐mimetic approach for fabricating robust multilamellar lipid vesicles to enhance in vivo delivery and stabilization of protein antigens is presented. This method leverages 1‐O‐acylceramide, a natural skin lipid, to facilitate the self‐assembly of lipid nanovesicles. Incorporating 1‐O‐acylceramide, anchoring lipid bilayers akin to its role in the stratum corneum, provides excellent stability under environmental stresses, including freeze–thaw cycles. Encapsulating ovalbumin as a model antigen and the adjuvant monophosphoryl lipid A demonstrates the vesicle's potential as a nanovaccine platform. In vitro studies show enhanced immune responses with both unilamellar and multilamellar vesicles, but in vivo analyses highlight the superior efficiency of multilamellar vesicles in inducing higher antibody and cytokine levels. This work suggests ceramide‐induced multilamellar lipid vesicles as an effective nanovaccine platform for enhanced antigen delivery and stability.Keywords
Funding Information
- Korea Health Industry Development Institute
This publication has 57 references indexed in Scilit:
- Conjugation‐Free Multilamellar Protein‐Lipid Hybrid Vesicles for Multifaceted Immune ResponsesAdvanced Healthcare Materials, 2021
- Application of Mannose‐Functionalized Microgel as a Novel Vaccine Delivery Platform for Subunit VaccinesAdvanced Functional Materials, 2021
- High-precision thickness control of ice layer on CVD grown bilayer graphene for cryo-TEMCarbon, 2020
- Engineering a Nanoscale Al‐MOF‐Armored Antigen Carried by a “Trojan Horse”‐Like Platform for Oral Vaccination to Induce Potent and Long‐Lasting ImmunityAdvanced Functional Materials, 2019
- Combination drug delivery via multilamellar vesicles enables targeting of tumor cells and tumor vasculatureBiotechnology and Bioengineering, 2018
- DNA Lipoplex‐Based Light‐Harvesting AntennaeAdvanced Functional Materials, 2017
- Crosslinked multilamellar liposomes for controlled delivery of anticancer drugsBiomaterials, 2013
- Synthesis and delivery activity of new cationic cholesteryl glucosidesCarbohydrate Research, 2010
- PEGylation of therapeutic proteinsBiotechnology Journal, 2010
- Endocytosis mechanisms and the cell biology of antigen presentationCurrent Opinion in Immunology, 2008